Bal Pharma Limited (BALPHARMA) - Total Assets

Latest as of March 2026: Rs3.76 Billion INR ≈ $40.61 Million USD

Based on the latest financial reports, Bal Pharma Limited (BALPHARMA) holds total assets worth Rs3.76 Billion INR (≈ $40.61 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BALPHARMA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Bal Pharma Limited - Total Assets Trend (2006–2026)

This chart illustrates how Bal Pharma Limited's total assets have evolved over time, based on quarterly financial data. Explore Bal Pharma Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.

Bal Pharma Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Bal Pharma Limited's total assets of Rs3.76 Billion consist of 69.8% current assets and 30.2% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	1.9%
Accounts Receivable	Rs947.98 Million	25.2%
Inventory	Rs1.16 Billion	31.0%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs134.22 Million	3.6%
Goodwill	Rs38.27 Million	1.0%

Asset Composition Trend (2006–2026)

This chart illustrates how Bal Pharma Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BALPHARMA market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Bal Pharma Limited's current assets represent 69.8% of total assets in 2026, an increase from 66.9% in 2006.
Cash Position: Cash and equivalents constituted 1.9% of total assets in 2026, down from 6.0% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is inventory at 31.0% of total assets.

Bal Pharma Limited Competitors by Total Assets

Key competitors of Bal Pharma Limited based on total assets are shown below.

Company	Country	Total Assets
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
SIMCERE PHARMAC. GRP LTD F:S2P	Germany	€14.73 Billion
Curaleaf Holdings Inc. TO:CURA	Canada	CA$2.88 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Walvax BioTech SHE:300142	China	CN¥11.13 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion

Bal Pharma Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.05	1.07	1.08
Quick Ratio	0.59	0.60	0.68
Cash Ratio	0.00	0.04	0.00
Working Capital	Rs130.06 Million	Rs153.72 Million	Rs116.14 Million

Bal Pharma Limited - Advanced Valuation Insights

This section examines the relationship between Bal Pharma Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.67
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	11.9%
Total Assets	Rs3.76 Billion
Market Capitalization	$15.12 Million USD

Valuation Analysis

Below Book Valuation: The market values Bal Pharma Limited's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Bal Pharma Limited's assets grew by 11.9% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Bal Pharma Limited (2006–2026)

The table below shows the annual total assets of Bal Pharma Limited from 2006 to 2026.

Year	Total Assets	Change
2026-03-31	Rs3.76 Billion ≈ $40.61 Million	+11.87%
2025-03-31	Rs3.36 Billion ≈ $36.30 Million	+5.06%
2024-03-31	Rs3.20 Billion ≈ $34.56 Million	+2.03%
2023-03-31	Rs3.13 Billion ≈ $33.87 Million	+20.20%
2022-03-31	Rs2.61 Billion ≈ $28.18 Million	+8.52%
2021-03-31	Rs2.40 Billion ≈ $25.96 Million	+0.71%
2020-03-31	Rs2.38 Billion ≈ $25.78 Million	-8.77%
2019-03-31	Rs2.61 Billion ≈ $28.26 Million	+3.77%
2018-03-31	Rs2.52 Billion ≈ $27.23 Million	+9.38%
2017-03-31	Rs2.30 Billion ≈ $24.90 Million	+9.09%
2016-03-31	Rs2.11 Billion ≈ $22.82 Million	+28.78%
2015-03-31	Rs1.64 Billion ≈ $17.72 Million	+5.89%
2014-03-31	Rs1.55 Billion ≈ $16.73 Million	+3.27%
2013-03-31	Rs1.50 Billion ≈ $16.20 Million	+6.14%
2012-03-31	Rs1.41 Billion ≈ $15.27 Million	+4.33%
2011-03-31	Rs1.35 Billion ≈ $14.63 Million	+8.94%
2010-03-31	Rs1.24 Billion ≈ $13.43 Million	+2.19%
2009-03-31	Rs1.22 Billion ≈ $13.14 Million	+11.66%
2008-03-31	Rs1.09 Billion ≈ $11.77 Million	+20.23%
2007-03-31	Rs905.28 Million ≈ $9.79 Million	+2.75%
2006-03-31	Rs881.03 Million ≈ $9.53 Million	--

About Bal Pharma Limited

NSE:BALPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$15.12 Million

Rs1.40 Billion INR

Market Cap Rank

#25973 Global

#1436 in India

Share Price

Rs87.79

Change (1 day)

-0.20%

52-Week Range

Rs60.42 - Rs103.59

All Time High

Rs151.23